Julie B. Feder, Chief Financial Officer at Aura Biosciences, Inc. (AURA), sold 3,385 shares at $6.82 ($23K) on 2023-10-30, disclosed to the SEC on 2023-11-01.
Open-market sale of $23k AURA by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AURA | SELL | 2023-11-07 | $47K | — | Filing → |
| AURA | SELL | 2022-11-02 | $25K | — | Filing → |